NEW YORK (Reuters Health) - Among premenopausal women taking steroids for
lupus, various treatments preserve bone mineral density and "should be
considered" for preventing the bone-thinning disease osteoporosis, advise
researchers in a report published this month.
Lupus, technically known as systemic lupus erythematosus or SLE, is a
chronic "autoimmune" disease in which the immune system can confuse healthy
and foreign tissues and sometimes attacks both.
"Whether due to the corticosteroid treatment, or to the disease itself,
osteoporosis is being increasingly recognized in patients with SLE," Dr.
Swan S. Yeap, of the University of Malaya, Kuala Lumpur, and colleagues
explain in the Journal of Rheumatology.
Yeap's team assessed changes over 2 years in bone mineral density (BMD) in
98 premenopausal women with SLE on long-term steroid therapy while taking
calcium only, calcium plus calcitriol (the active form of vitamin D) or
calcium plus the bone-strengthening drug alendronate (Fosamax).
Women taking calcium plus alendronate saw significant increases in BMD at
both the lumbar spine (2.69 percent) and hip (1.41 percent) compared to
baseline, the researchers report.
In contrast, there were no significant changes found in the calcium-only and
the calcium plus calcitriol groups, except for a 0.93 percent reduction in
hip BMD in the calcium-only group. The medications were well tolerated.
In premenopausal women taking steroids for SLE, the researchers conclude,
bone mineral density can be preserved or increased with prophylactic
therapy.
SOURCE: Journal of Rheumatology, December 2008.
ironjustice@aol.com - 30 Dec 2008 21:42 GMT
osteoporosis is being increasingly recognized in patients with SLE <<
Seeing that lupus is related to sickle it should then be no surprise
everyone with sickle ALSO are prone to osteoporosis ..
Sickle cell anaemia: is it a cause for secondary osteoporosis?
Published in West Afr J Med. 2007 Apr-Jun;26(2):134-7.
Sadat-Ali M, Al Elq AH.
Department of Orthpaedic Surgery, King Fahd University Hospital, Al-
Khobar, Saudi Araia. drsadat@hotmail.com
OBJECTIVE:
The risk of osteoporosis and osteopenia i s patients with sickle cell
anaemia is not well established. This prospective study was conducted
to assess the prevalence of osteoporosis and osteopenia in sickle cell
anaemia.
METHODS:
Consecutive adult sickle cell anaemia patients who were treated at the
department of orthopaedic surgery of King Fahd University Hospital,
AIKhobar, SaudiArabia, between April and July 2006, were the subjects
of study. After a verbal consent to participate in the study, patients
age and sex were documented and body mass index (BMI) was calculated.
Blood was extracted for haematological and biochemistry which also
included haemoglobin electrophoresis. Bone mineral density (BMD)
measurement was done using dual energy x-rayabsorbtiometry (DEXA) at
the lumbar spine and the upper femur. Osteopenia and osteoporosis was
diagnosed as per the WHO criteria.
RESULTS:
The results of 36 patients were analyzed. There were 23 males and 13
females. The average age in males was 34.21+/-6.35 years, and females
was 35.38+/-5.40 years. Eighty-two percent of males and 76% of the
females were either osteopenic or osteoporotic. The prevalence of
osteoporosis in males was highest at lumbar spine (P= 0.001).
CONCLUSIONS:
This study finds the prevalence of osteopenia and osteoporosis is
quite high among Saudi adult SCA patients. Physicians should be aware
of the risk of osteoporosis in sickle cell patients and every effort
should be made to treat them adequately and prevent osteoporosis
related fractures.
Who loves ya.
Tom
Jesus Was A Vegetarian!
http://tinyurl.com/634q5a
Man Is A Herbivore!
http://tinyurl.com/4rq595
DEAD PEOPLE WALKING
http://tinyurl.com/zk9fk
> NEW YORK (Reuters Health) - Among premenopausal women taking steroids for
> lupus, various treatments preserve bone mineral density and "should be
[quoted text clipped - 28 lines]
>
> SOURCE: Journal of Rheumatology, December 2008.